Abstract
Recent studies showed gadolinium depositions following serial administrations of gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging examinations in various parts of the brain with the dentate nucleus (DN) being most affected. Even though no clinical correlates of the deposits are known yet, an intensive debate developed if this might be harmful. The aim of the current study was to specify the gadolinium distribution in brain tissue of patients who received serial injections of GBCAs in the low-µm range and to explore any potential pathological tissue changes caused by gadolinium deposits. Thirteen autopsy cases—eight receiving GBCA administrations, five serving as controls—were identified and analyzed. For all patients, total gadolinium quantification after acidic digestion by means of inductively coupled plasma-mass spectrometry (ICP-MS) was performed. Six cases were utilized for the spatially resolved quantification of gadolinium within the cerebellum and the basal ganglia by means of high-resolution laser ablation (LA)-ICP-MS. Histopathological and immunohistochemical examinations were performed to determine tissue reactions. LA-ICP-MS revealed gadolinium depositions in the walls of small blood vessels of the DN in all GBCA exposed patients, while no gadolinium was found in the control group. Additionally, the detection of phosphorus and metals like copper, zinc and iron provides evidence that transmetalation reactions might have occurred. No significant pathological changes of the brain tissue in the vicinity of the DN with respect to micro-/astrogliosis and neuronal loss were found in any of the patients. This notably holds true even for a patient who died from nephrogenic systemic fibrosis exhibiting extremely high gadolinium concentrations within the DN. The findings show that gadolinium depositions in the brain are restricted to blood vessel walls, while the neuropil is spared and apparent cellular reactions are absent.
Similar content being viewed by others
References
Aime S, Caravan P (2009) Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J Magn Reson Imaging 30:1259–1267. https://doi.org/10.1002/jmri.21969
Birka M, Wentker KS, Lusmöller E, Arheilger B, Wehe CA, Sperling M, Stadler R, Karst U (2015) Diagnosis of nephrogenic systemic fibrosis by means of elemental bioimaging and speciation analysis. Anal Chem 87:3321–3328. https://doi.org/10.1021/ac504488k
Cao Y, Huang DQ, Shih G, Prince MR (2016) Signal change in the dentate nucleus on T1-weighted MR images after multiple administrations of gadopentetate dimeglumine versus gadobutrol. Am J Roentgenol 206:414–419. https://doi.org/10.2214/Ajr.15.15327
Cao Y, Zhang Y, Shih G, Zhang Y, Bohmart A, Hecht EM, Prince MR (2016) Effect of renal function on gadolinium-related signal increases on unenhanced T1-weighted brain magnetic resonance imaging. Investig Radiol 51:677–682. https://doi.org/10.1097/Rli.0000000000000294
Fingerhut S, Niehoff AC, Sperling M, Jeibmann A, Paulus W, Niederstadt T, Allkemper T, Heindel W, Holling M, Karst U (2018) Spatially resolved quantification of gadolinium deposited in the brain of a patient treated with gadolinium-based contrast agents. J Trace Elem Med Biol 45:125–130. https://doi.org/10.1016/j.jtemb.2017.10.004
Frenzel T, Apte C, Jost G, Schockel L, Lohrke J, Pietsch H (2017) Quantification and assessment of the chemical form of residual gadolinium in the brain after repeated administration of gadolinium-based contrast agents comparative study in rats. Investig Radiol 52:396–404. https://doi.org/10.1097/Rli.0000000000000352
Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann HJ (2008) Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Investig Radiol 43:817–828
Greenberg SA (2010) Zinc transmetallation and gadolinium retention after MR imaging: case report. Radiology 257:670–673. https://doi.org/10.1148/radiol.10100560
Grobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1745. https://doi.org/10.1093/ndt/gfl294
Guerbet (2017) Advisory committee briefing document. Medical Imaging Drug Advisory Committee (MIDAC), 8 Sep 2017
Hachmöller O, Aichler M, Schwamborn K, Lutz L, Werner M, Sperling M, Walch A, Karst U (2016) Element bioimaging of liver needle biopsy specimens from patients with Wilson’s disease by laser ablation-inductively coupled plasma-mass spectrometry. J Trace Elem Med Biol 35:97–102. https://doi.org/10.1016/j.jtemb.2016.02.001
Hao DP, Ai T, Goerner F, Hu XM, Runge VM, Tweedle M (2012) MRI contrast agents: basic chemistry and safety. J Magn Reson Imaging 36:1060–1071. https://doi.org/10.1002/jmri.23725
Jost G, Frenzel T, Lohrke J, Lenhard DC, Naganawa S, Pietsch H (2017) Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue. Eur Radiol 27:2877–2885. https://doi.org/10.1007/s00330-016-4654-2
Jost G, Lenhard DC, Sieber MA, Lohrke J, Frenzel T, Pietsch H (2016) Signal increase on unenhanced T1-weighted images in the rat brain after repeated, extended doses of gadolinium-based contrast agents comparison of linear and macrocyclic agents. Investig Radiol 51:83–89. https://doi.org/10.1097/Rli.0000000000000242
Kanda T, Fukusato T, Matsuda M, Toyoda K, Oba H, Kotoku J, Haruyama T, Kitajima K, Furui S (2015) Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 276:228–232. https://doi.org/10.1148/radiol.2015142690
Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270:834–841. https://doi.org/10.1148/radiol.13131669
Kanda T, Osawa M, Oba H, Toyoda K, Kotoku J, Haruyama T, Takeshita K, Furui S (2015) High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 275:803–809. https://doi.org/10.1148/radiol.14140364
Künnemeyer J, Terborg L, Nowak S, Brauckmann C, Telgmann L, Albert A, Tokmak F, Krämer BK, Günsel A, Wiesmüller GA et al (2009) Quantification and excretion kinetics of a magnetic resonance imaging contrast agent by capillary electrophoresis-mass spectrometry. Electrophoresis 30:1766–1773. https://doi.org/10.1002/elps.2008-00831
Künnemeyer J, Terborg L, Nowak S, Telgmann L, Tokmak F, Krämer BK, Günsel A, Wiesmüller GA, Waldeck J, Bremer C et al (2009) Analysis of the contrast agent magnevist and its transmetalation products in blood plasma by capillary electrophoresis/electrospray ionization time-of-flight mass spectrometry. Anal Chem 81:3600–3607. https://doi.org/10.1021/ac8027118
Lauffer RB (1987) Paramagnetic metal-complexes as water proton relaxation agents for NMR imaging—theory and design. Chem Rev 87:901–927. https://doi.org/10.1021/Cr00081a003
Lohrke J, Frisk AL, Frenzel T, Schöckel L, Rosenbruch M, Jost G, Lenhard DC, Sieber MA, Nischwitz V, Küppers A et al (2017) Histology and gadolinium distribution in the rodent brain after the administration of cumulative high doses of linear and macrocyclic gadolinium-based contrast agents. Investig Radiol 52:324–333. https://doi.org/10.1097/Rli.0000000000000344
McDonald RJ, McDonald JS, Dai D, Schroeder D, Jentoft ME, Murray DL, Kadirvel R, Eckel LJ, Kallmes DF (2017) Comparison of gadolinium concentrations within multiple rat organs after intravenous administration of linear versus macrocyclic gadolinium chelates. Radiology. https://doi.org/10.1148/radiol.2017161594
McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275:772–782. https://doi.org/10.1148/radiol.15150025
Murata N, Gonzalez-Cuyar LF, Murata K, Fligner C, Dills R, Hippe D, Maravilla KR (2016) Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue preliminary results from 9 patients with normal renal function. Investig Radiol. https://doi.org/10.1097/rli.0000000000000252
Niehaus R, Sperling M, Karst U (2015) Study on aerosol characteristics and fractionation effects of organic standard materials for bioimaging by means of LA-ICP-MS. J Anal Atom Spectrom 30:2056–2065. https://doi.org/10.1039/c5ja00221d
Niehoff AC, Bauer OB, Kröger S, Fingerhut S, Schulz J, Meyer S, Sperling M, Jeibmann A, Schwerdtle T, Karst U (2015) Quantitative bioimaging to investigate the uptake of mercury species in Drosophila melanogaster. Anal Chem 87:10392–10396. https://doi.org/10.1021/acs.analchem.5b02500
Oksendal AN, Hals PA (1993) Biodistribution and toxicity of MR imaging contrast-media. JMRI J Magn Reson Imaging 3:157–165. https://doi.org/10.1002/jmri.1880030128
Puttagunta NR, Gibby WA, Smith GT (1996) Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents. Investig Radiol 31:739–742. https://doi.org/10.1097/00004424-199612000-00001
Radbruch A, Haase R, Kieslich PJ, Weberling LD, Kickingereder P, Wick W, Schlemmer HP, Bendszus M (2017) No signal intensity increase in the dentate nucleus on unenhanced T1-weighted MR images after more than 20 serial injections of macrocyclic gadolinium-based contrast agents. Radiology 282:699–707. https://doi.org/10.1148/radiol.2016162241
Radbruch A, Roberts DR, Clement O, Rovira A, Quattrocchi CC (2017) Chelated or dechelated gadolinium deposition. Lancet Neurol 16:955
Radbruch A, Weberling LD, Kieslich PJ, Eidel O, Burth S, Kickingereder P, Heiland S, Wick W, Schlemmer HP, Bendszus M (2015) Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 275:783–791. https://doi.org/10.1148/radiol.2015150337
Radbruch A, Weberling LD, Kieslich PJ, Hepp J, Kickingereder P, Wick W, Schlemmer HP, Bendszus M (2015) High-signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images evaluation of the macrocyclic gadolinium-based contrast agent gadobutrol. Investig Radiol 50:805–810. https://doi.org/10.1097/Rli.0000000000000227
Ramalho J, Castillo M, AlObaidy M, Nunes RH, Ramalho M, Dale BM, Semelka RC (2015) High signal intensity in globus pallidus and dentate nucleus on unenhanced T1-weighted MR images: evaluation of two linear gadolinium-based contrast agents. Radiology 276:836–844. https://doi.org/10.1148/radiol.2015150872
Robert P, Lehericy S, Grand S, Violas X, Fretellier N, Idee JM, Ballet S, Corot C (2015) T1-weighted hypersignal in the deep cerebellar nuclei after repeated administrations of gadolinium-based contrast agents in healthy rats difference between linear and macrocyclic agents. Investig Radiol 50:473–480. https://doi.org/10.1097/Rli.0000000000000181
Roberts DR, Welsh CA, LeBel DP 2nd, Davis WC (2017) Distribution map of gadolinium deposition within the cerebellum following GBCA administration. Neurology 88:1206–1208. https://doi.org/10.1212/WNL.0000000000003735
Runge VM (2017) Critical questions regarding gadolinium deposition in the brain and body after injections of the gadolinium-based contrast agents, safety, and clinical recommendations in consideration of the EMA’s pharmacovigilance and risk assessment committee recommendation for suspension of the marketing authorizations for 4 linear agents. Investig Radiol 52:317–323. https://doi.org/10.1097/Rli.0000000000000374
Runge VM, Stewart RG, Clanton JA, Jones MM, Lukehart CM, Partain CL, James AE (1983) Potential oral and intravenous paramagnetic NMR contrast agents. Radiology 147:789–791
Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9(7):676–682. https://doi.org/10.1038/nmeth.2019
Telgmann L, Wehe CA, Künnemeyer J, Bülter AC, Sperling M, Karst U (2012) Speciation of Gd-based MRI contrast agents and potential products of transmetalation with iron ions or parenteral iron supplements. Anal Bioanal Chem 404:2133–2141. https://doi.org/10.1007/s00216-012-6404-x
Tweedle MF, Hagan JJ, Kumar K, Mantha S, Chang CA (1991) Reaction of gadolinium chelates with endogenously available ions. Magn Reson Imaging 9:409–415. https://doi.org/10.1016/0730-725x(91)90429-P
Vanwagoner M, Otoole M, Worah D, Leese PT, Quay SC (1991) A phase-I clinical-trial with gadodiamide injection, a nonionic magnetic-resonance-imaging enhancement agent. Investig Radiol 26:980–986
Vanwagoner M, Worah D (1993) Gadodiamide injection—1st human-experience with the nonionic magnetic-resonance-imaging enhancement agent. Investig Radiol 28:S44–S48
Weinmann HJ, Laniado M, Mutzel W (1984) Pharmacokinetics of GdDTPA dimeglumine after intravenous-injection into healthy-volunteers. Physiol Chem Phys 16:167–172
Yang XC, Sachs F (1989) Block of stretch-activated ion channels in xenopus oocytes by gadolinium and calcium-ions. Science 243:1068–1071. https://doi.org/10.1126/science.2466333
Acknowledgements
We thank Prof. Klapper, Institute of Pathology, Kiel for providing the CD68-antibody and Andrea Rothaus for expert technical assistance.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethical statement
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Informed consent
Informed consent was obtained from all individual participants included in the study. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article (if identifying information about participants is available).
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fingerhut, S., Sperling, M., Holling, M. et al. Gadolinium-based contrast agents induce gadolinium deposits in cerebral vessel walls, while the neuropil is not affected: an autopsy study. Acta Neuropathol 136, 127–138 (2018). https://doi.org/10.1007/s00401-018-1857-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-018-1857-4